←
Dermatology Times24,313 posts
Dermatology Times avatar

Dermatology Times

@DermTimesNow

A leading news resource serving dermatology clinicians.

◷ Joined July 2009▧ 7,455 Photos and videos
Dermatology Times avatar
Dermatology Times@DermTimesNow·7m

💉 THE AESTHETIC EDGE: Bioelements and Celluma are joining forces to bring LED light therapy into professional facial treatments. 🔗 Read more: hubs.li/Q04FJB2T0 #AestheticDermatology #LEDLightTherapy #SkinCare #Dermatology

Dermatology Times avatar
Dermatology Times@DermTimesNow·7m

💡 EXPERT COMMENTARY: Could a more comprehensive approach to indoor tanning prevention help reduce melanoma risk? 🔗 Read more: hubs.li/Q04FJBRs0 #MelanomaPrevention #SkinCancerAwareness #IndoorTanning #Dermatology

Dermatology Times avatar
Dermatology Times@DermTimesNow·Nov 17

💡 EXPERT INSIGHTS: Mark G. Lebwohl, MD, discusses anticipated monitoring requirements, the differences between oral and injectable therapies, and how disease severity and patient preferences can guide individualized treatment decisions. 🎥 Watch now: hubs.li/Q04FpLnW0

Dermatology Times avatar
Dermatology Times@DermTimesNow·Nov 16

🚨 FDA UPDATE: The FDA has implemented updated iPLEDGE REMS requirements for isotretinoin, introducing changes to the program designed to prevent fetal exposure during treatment. 🔗 Read more: hubs.li/Q04FpM3w0 #Isotretinoin #iPLEDGE #FDAUpdate #Dermatology

Dermatology Times avatar
Dermatology Times@DermTimesNow·Nov 16

📉 CLINICAL TRIAL UPDATE: Aclaris Therapeutics' investigational antibody bosakitug failed to meet the primary and secondary efficacy end points in a phase 2 trial for moderate to severe atopic dermatitis. hubs.li/Q04FpG-b0 #Bosakitug #AclarisTherapeutics

Dermatology Times avatar
Dermatology Times@DermTimesNow·Nov 16

📚 JOURNAL DIGEST: Stay up to date with the latest research shaping dermatology practice in this week's Dermatology Times Journal Digest. 🔗 Read the November 16 edition: hubs.li/Q04FpHJc0 #JournalDigest #DermatologyResearch #Dermatology

Dermatology Times avatar
Dermatology Times@DermTimesNow·Nov 15

In the latest episode of Don't Be Rash, host Andrew Krakowski, MD, is joined by Joseph Lam, MD, FRCPC, of BC Children's Hospital, to discuss how clinicians can distinguish benign birthmarks from early signs of NF1 and related conditions. hubs.li/Q04FgndW0

Dermatology Times avatar
Dermatology Times@DermTimesNow·Nov 13

How early should clinicians consider biologic therapy for children with atopic dermatitis? Mark G. Lebwohl, MD, of the Icahn School of Medicine at Mount Sinai, discusses the importance of skin barrier protection. hubs.li/Q04FgSJQ0

Dermatology Times avatar
Dermatology Times@DermTimesNow·Nov 13

The latest episode of #DontBeRash is now live! In this episode, host Dr. Krakowski sits down with leading expert Dr. Joseph Lam for a deep dive into how CALM count, size, age, and associated findings separate benign spots from NF1 and its mimics. hubs.li/Q04Fc1Kb0

1:20
Dermatology Times avatar
Dermatology Times@DermTimesNow·Nov 12

💡 EXPERT INSIGHTS: For patients living with hidradenitis suppurativa (HS), support can extend beyond traditional medical treatment. Read more: hubs.li/Q04F8-Gk0 #HidradenitisSuppurativa #PetTherapy #MentalHealth #Dermatology

Dermatology Times avatar
Dermatology Times@DermTimesNow·Nov 12

⭐️ CASE-BASED INSIGHTS: Selecting a hedgehog inhibitor for advanced basal cell carcinoma (BCC) requires more than evaluating efficacy alone. Read more: hubs.li/Q04F8XcD0 #BasalCellCarcinoma #BCC #SkinCancer #Dermatology